Ethics And Racial Health Care Disparities

New technology and medical advances have provided an assurance for healthier, longer lives than before to most of the people in the United States. With such advancement in medicine in the United States, it is evident that some groups have worst health as compared to others. The major causes of such differences are persistent and disparities that exist between different racial and ethnic populaces and equity in the health sector remain an issue. The social conditions in which most people live are core drivers of differences in health outcomes that are associated with environmental, social and economic factors (Morgan & Carrasquillo, 2013).

If this sample essay on"Ethics And Racial Health Care Disparities" doesn’t help,
our writers will!

Trust an expert

The Alzheimers diseases among African-American have been identified as an emerging public health crisis according to Alzheimers Association. Studies show that there is a larger family risk of Alzheimers in African-American. The disease is more common in African American that the whites with estimates ranging from 15% to almost 100% higher. The generic and environmental factors have worked differently to cause the disease among the blacks (Morgan & Carrasquillo, 2013). The shift in both racial composition and age poses a major challenge to older African American population as the increasing body evidence advocates that African-Americans have the greater risk of Alzheimers disease. Studies have shown that vascular diseases among African- American are behind the mechanisms in triggering the symptom of Alzheimers disease.

A major factor of Alzheimer's disease is the age and the number of African American entering age of risk is at the alarming rate. This means that most of them are becoming more vulnerable to this disease. Racial disparities in Alzheimers disease have contributed to the growth of the disease. The ethnic and cultural favoritism in the current screening assessment tool is well known (Morgan & Carrasquillo, 2013). This has led to increased high rate of false-positive results among the African American who have been screened. The treatment of the disease depend on early detection but it is so clear that most African-American tends to be diagnosed in the later stages of the diseases and this restricts the efficiency of treatment. Furthermore, generic differences and response drugs vary extensively by race and ethnicity. But when it comes to clinical trials for the potential treatment of Alzheimers African-American are not represented. This raises a question of the effectiveness of the current treatment being offered to African-American (Morgan & Carrasquillo, 2013).

However, African- American can come with strategies that can enable them to take control of their health. African-American should form a Diversity Work Group of leading African- American researchers mandated with working on Alzheimers disease in different cultures in order to help the society to identify priorities for future research. The work group should collaborate with the National Institute on Aging in order to realize the objective of the group together.

Diabetes is a major health issue in the United States, the worst part of this prevalence is that it affects racial and ethnic populace, including Hispanics. In the United States, it is estimated that 8% of the population had diabetes while 57 million people were anticipated to have pre-diabetes, a condition that increments the risk of developing type 2 diabetes. (Lopez & Golden, 2014) The disease causes mortality and morbidity in every individual. However, the study shows that Hispanics are two times likely to get diabetes as compared to non-Hispanic whites. Furthermore, in the year 2005, Hispanics were 1.6 likely to die from diabetes and they experience much higher diabetes mortality. The reason why diabetes remains so prevalent among the Hispanic is that they experience lower levels of physical activity, poor eating habits, and higher cholesterol level. Ethics and health care disparities have played a major role in the growth of diabetes among the Hispanics. To begin with, there is a little availability of national level data about the commonness of diabetes in a Hispanic populace. The provision of lower quality of care to the Hispanic populace is may be the major contributor to the current state of diabetes among Hispanic people. It has also been found that whites are more likely to have dilated ophthalmologic examination than the Hispanics (Lopez & Golden, 2014).. Very little research has been done on Hispanics in order to better understand why this group of people is prone to diabetes as compared to non-Hispanics. in the united states, a lot of research have been done on non-Hispanics and more measures have been provided to this people as there is more information as compared to Hispanics. The treatment of the disease depend on early diagnose but it is so clear that most African-American tends to be diagnosed in the later stages of the diseases and this restricts the efficiency of treatment. This menace should not remain a threat to Hispanics as they can fight it for themselves. The Hispanics should invest in developing and strengthening of community programs that link consumers to culturally skillful and linguistically suitable diabetes awareness and education services (Lopez & Golden, 2014).

The health disparities being experienced at the united state are not saving any situation at all but rather they are worsening everything. The population of individuals who are suffering from diabetes and Alzheimers diseases is going to increase and this the time the health sector will spend more money in handling this situation as compared as it is at the moment. It is the highest time the movement should step in and revive the health sector and promote equality in the entire sector in order to reach the suffering minorities.

Reference

Lopez, L. & Golden, S. (2014). A New Era in Understanding Diabetes Disparities Among U.S. LatinosAll

Are Not Equal. Diabetes Care, 37(8), 2081-2083. http://dx.doi.org/10.2337/dc14-0923Morgan, K., & Carrasquillo, M. M. (2013). Genetic Variants in Alzheimers Disease. Springer Science & Business Media.